Cargando…
Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
BACKGROUND: Skeletal muscle atrophy is defined as a reduction of muscle mass caused by excessive protein degradation. However, the development of therapeutic interventions is still in an early stage. Although glucagon‐like peptide‐1 receptor (GLP‐1R) agonists, such as exendin‐4 (Ex‐4) and dulaglutid...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711418/ https://www.ncbi.nlm.nih.gov/pubmed/31020810 http://dx.doi.org/10.1002/jcsm.12434 |